Welcome to www.legeartisgroup.com - the Lege Artis Website
Lege Artis joined the i3 group of companies in April 2008.
i3 is a global Ingenix company, providing integrated scientific strategies and solutions throughout the pharmaceutical product lifecycle. It is composed of i3 Research, a therapeutically specialized contract research organization; i3 Drug Safety, engaged in pharmacovigilance and epidemiology; i3 Pharma Informatics, a data, science and technology provider of market analytics; i3 Statprobe, a leader in comprehensive data services; i3 Pharma Resourcing, a world-class staffing partner; and i3 Innovus, delivering the science and solutions to achieve marketplace success. i3 helps companies gain sharper insights that lead to better patient care.
The addition of Lege Artis and its capabilities in Belarus and Ukraine will provide i3 Research customers enhanced access to experienced investigators in Russia and the neighboring states of the former Soviet Union.
Founder and CEO, Tatjana Zwereva , MD, PhD, will lead the new Russian company. She will continue to be supported by her experienced management team, including Alexander Makarkov, MD, PhD, and co-founder of Lege Artis. “We are pleased to join the i3 family of companies, which is known for its emphasis on quality in its research, data, staff and relationships,” said Zwereva. “There is a good fit between our organizations, and we believe that we can make great strides together.”
Please find below our contact information in Moscow:
i3 LLC
1st Truzhenikov per. 12 | bld. 1
Moscow | Russia | 119121
Tel +7 (495) 248 3154 | Fax +7 (495) 626 9711
For more information about how i3 may be of service to you, please visit www.i3global.com or click on a link below:
Clinical Research
Health economics & Outcomes research
Clinical data services
Pharma Informatics
Staffing solutions
Drug safety
|
